BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Stem Cells Show Promise in Halting Heart Attack’s Ripple Effect, University of Maryland School of Medicine Study


9/7/2012 7:55:50 AM

Durham, NC – A new pre-clinical study demonstrates how stem cells may significantly reduce the ripple-effect damage caused by a heart attack. The study, by researchers at the University of Maryland School of Medicine in Baltimore, appears in the September issue of STEM CELLS Translational Medicine.

Several recent clinical trials have shown how stem cells can help the heart heal after an attack, but to date the investigations have focused on transplanting cells directly into the site of the attack itself. However, a heart attack has a ripple effect, much like how an earthquake reaches beyond its epicenter to affect outlying regions, too. As the heart attempts to shift the workload from the damaged section to surrounding healthy muscle, the tissue abutting the attack site gets caught in the middle. This often results in the tissue being overstressed and leads to cardiac failure.

In this new study, the researchers evaluated the effects of expanding the stem cell treatment beyond the heart attack site to include the surrounding region.

“We wanted to look specifically at whether mesenchymal stem cells (MSCs) improve the remodeling of the myocardium directly abutting the attack site,” explained Zhongium Wu, Ph.D., associate professor of surgery at the University of Maryland School of Medicine and a principal investigator in the study. “In other words, could they prevent changes to the heart’s size, shape, structure and physiology resulting from the injury to its muscular tissue?”

Using pre-clinical models, researchers treated half of the group with MSCs and left the other half untreated. Each subject receiving the MSCs was treated with allogeneic stem cells to prevent rejection. The MSCs were collected from the bone marrow, then modified in the lab before being re-transplanted using a series of six injections. MSCs were employed because they give rise to a variety of cell types. Three months later, they examined the results and were excited by what they found.

“Along with protecting the adjacent area from structural damage and strain, the MSCs prevented other common side effects of a heart attack including cardiac hypertrophy, or enlargement, which is generally the result of an imbalance in calcium brought on by an attack. They also reduced cardiac apoptosis in which the heart cells basically commit suicide,” said Bartley P. Griffith, M.D., Thomas E. and Alice Marie Hales Distinguished Professor, professor of surgery at the University of Maryland School of Medicine and director of heart and lung transplantation at the University of Maryland Comprehensive Heart Center. He and Dr. Wu, along with Zhao Yunshan, Ph.D., and Tieluo Li, M.D., made up the study’s leadership team.

“We believe the study provides an important view into how MSC transplantation may benefit the region adjacent to the heart attack site, said Griffith. The results merit further investigation.”

“This study provides new evidence detailing the therapeutic effects of MSC transplantation on progressive cardiac remodeling following a heart attack,” said Anthony Atala, M.D., Editor of STEM CELLS Translational Medicine and director of the Wake Forest Institute for Regenerative Medicine.



Read at BioSpace.com
Read at PRWEB

 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES